Repligen (RGEN) EPS (Basic) Growth (1y) (2011 - 2026)
Powered by 
Analysis
Repligen (RGEN) EPS (Basic) Growth (1y) (2011 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 223.99 Bn | 219.93 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 141.56 Bn | 137.22 Bn | 3.61 Bn | 59.25% |
| 3 | Agilent Technologies | 40.36 Bn | 38.60 Bn | 1.04 Bn | 8.50% |
| 4 | Illumina | 30.41 Bn | 29.24 Bn | 770.00 Mn | -8.41% |
| 5 | Revvity | 13.50 Bn | 12.48 Bn | 416.87 Mn | 1.16% |
| 6 | Bio-Techne | 11.25 Bn | 10.98 Bn | 211.39 Mn | 180.15% |
| 7 | Bio-Rad Laboratories | 9.88 Bn | 8.26 Bn | 345.80 Mn | 18.96% |
| 8 | Repligen | 9.29 Bn | 8.28 Bn | 110.04 Mn | -66.42% |
| 9 | 10x Genomics | 8.62 Bn | 8.06 Bn | 112.50 Mn | -149.43% |
| 10 | Bruker | 8.16 Bn | 7.94 Bn | 416.00 Mn | -923.83% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -66.42% |
| Mar 31, 2026 | 43.01% |
| Dec 31, 2025 | 129.53% |
| Sep 30, 2025 | 2,365.02% |
| Jun 30, 2025 | 158.59% |
| Mar 31, 2025 | 75.89% |
| Dec 31, 2024 | -1,430.60% |
| Sep 30, 2024 | -103.86% |
| Jun 30, 2024 | -71.22% |
| Mar 31, 2024 | -88.61% |
| Dec 31, 2023 | -82.76% |
| Sep 30, 2023 | -58.32% |
| Jun 30, 2023 | -60.50% |
| Mar 31, 2023 | -39.38% |
| Dec 31, 2022 | 66.05% |
| Sep 30, 2022 | 19.57% |
| Jun 30, 2022 | 36.34% |
| Mar 31, 2022 | -0.99% |
| Dec 31, 2021 | 324.35% |
| Sep 30, 2021 | 119.86% |